Leukapheresis: Clinical Trials

5 trials of Leukapheresis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 recruiting. 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 35Completed 3, Recruiting 2

Follow Leukapheresis: new trials by email Literature Review of Leukapheresis trials Research Report on Leukapheresis

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
Autologous Hematopoietic Stem Cell Transplantation, Best Practice, Biospecimen Collection - Anaplastic Large Cell Lymphoma, ALK-Negative, Follicular Helper T-Cell Lymphoma
Phase 3RecruitingEastern Cooperative Oncology Group2942025-06-182026-09-14
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3RecruitingNational Cancer Institute (NCI)4782024-04-192026-10-30
Two Different Methods of Collecting Stem Cells For an Autologous Stem Cell Transplant in Treating Patients With Diffuse Large Cell Lymphoma
autologous hematopoietic stem cell transplantation, leukapheresis - Lymphoma
Phase 3CompletedMayo Clinic1222007-12-012018-07-09
Intermittent vs. Continuous HAART to Treat Chronic HIV Infection
Leukapheresis - HIV Infection
Phase 3CompletedNational Institute of Allergy and Infectious Diseases (NIAID)902001-10-012008-03-04
Mobilization and Handling of Stem Cells for Transplant From Healthy Volunteers With Sickle Cell Trait
Granulocyte colony-stimulating factor, Leukapheresis - Sickle Cell Trait
Phase 3CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)122000-01-012008-03-04

Conditions studied

Ganglioneuroblastoma (1)  ·  HIV Infections (1)  ·  Lymphoma (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Large-Cell, Anaplastic (1)  ·  Lymphoma, T-Cell (1)  ·  Neuroblastoma (1)  ·  Sickle Cell Trait (1)

Sponsors

Eastern Cooperative Oncology Group (1)  ·  Mayo Clinic (1)  ·  National Cancer Institute (NCI) (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)

Countries

United States (5)  ·  Australia (1)  ·  Canada (1)  ·  Mexico (1)  ·  New Zealand (1)  ·  Puerto Rico (1)

Top investigators

Luis F. Porrata, MD (1)  ·  Nabila N Bennani (1)  ·  Sara M Federico (1)

Results publications

PMID 26826432, PMID 30978434

NIH funding

P30CA015083 (1), U10CA180820 (1), U10CA180886 (1)